Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Lexicon Pharmaceuticals, Inc.
Updated Jul 16, 2026
Amouyal Philippe has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | CAVA | CAVA GROUP, INC. | A — Grant or award | 1.9K | $0.00 | |
| 2026-06-04 | LXRX | LEXICON PHARMACEUTICALS, INC. | M — Option exercise | 89.3K | $0.00 | |
| 2025-05-13 | LXRX | LEXICON PHARMACEUTICALS, INC. | M — Option exercise | 36.8K | $0.00 |
Amouyal Philippe is a corporate insider — currently tracked as Director of CAVA GROUP, INC. (CAVA). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Amouyal Philippe profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.